Medolife Rx Announces Preclinical Trial Results From Toxicity Study on Lead Drug Candidate
BURBANK, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today preclinical trial results on its lead drug candidate Escozine …